Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Adrenergic alpha-Antagonists MeSH Descriptor Data 2025
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
Entry Version
ADREN ALPHA ANTAG
Entry Term(s)
Adrenergic alpha-Blockers
Adrenergic alpha-Receptor Blockaders
alpha-Adrenergic Antagonists
alpha-Adrenergic Blockers
alpha-Adrenergic Blocking Agents
alpha-Adrenergic Receptor Blockaders
alpha-Blockers, Adrenergic
Registry Numbers
0
NLM Classification #
QV 132
Previous Indexing
Sympatholytics (1966-1968)
Public MeSH Note
95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1973-94
Online Note
use ADRENERGIC ALPHA-ANTAGONISTS to search ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (as Prov 1969-72)
History Note
95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.